Together, these data suggest that increasing ARL13B at/in the cilium alters the SHH transduction pathway components inside glioma cilia, but that downstream pathways either fail to engage in our cells, or that there are non-canonical targets of these transduction events associated with an active SMO/GLI accumulation. The gene discussed is GLI1; the disease is central nervous system cancer.